- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.26 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 6 x ACO: ACETYL COENZYME *A(Non-covalent)
ACO.2: 20 residues within 4Å:- Chain A: T.824, L.829, P.830, H.831, G.832, G.1034, M.1036, T.1037, R.1053, L.1059, R.1061, K.1089, S.1092, M.1138, P.1141, I.1142, P.1143, F.1144, N.1145, R.1146
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:G.832, A:T.1037, A:T.1037, A:R.1053, A:R.1061, A:S.1092, A:I.1142, A:N.1145, A:N.1145, A:R.1146
- Salt bridges: A:H.831, A:K.1089, A:R.1146, A:R.1146
- pi-Cation interactions: A:R.1053
ACO.5: 20 residues within 4Å:- Chain B: T.824, L.829, P.830, H.831, G.832, G.1034, M.1036, T.1037, R.1053, L.1059, R.1061, K.1089, S.1092, M.1138, P.1141, I.1142, P.1143, F.1144, N.1145, R.1146
15 PLIP interactions:15 interactions with chain B- Hydrogen bonds: B:T.824, B:G.832, B:T.1037, B:T.1037, B:R.1053, B:S.1092, B:I.1142, B:N.1145, B:N.1145, B:R.1146
- Salt bridges: B:H.831, B:K.1089, B:R.1146, B:R.1146
- pi-Cation interactions: B:R.1053
ACO.8: 20 residues within 4Å:- Chain C: T.824, L.829, P.830, H.831, G.832, G.1034, M.1036, T.1037, R.1053, L.1059, R.1061, K.1089, S.1092, M.1138, P.1141, I.1142, P.1143, F.1144, N.1145, R.1146
15 PLIP interactions:15 interactions with chain C- Hydrogen bonds: C:G.832, C:T.1037, C:T.1037, C:R.1053, C:R.1061, C:S.1092, C:I.1142, C:N.1145, C:N.1145, C:R.1146
- Salt bridges: C:H.831, C:K.1089, C:R.1146, C:R.1146
- pi-Cation interactions: C:R.1053
ACO.11: 20 residues within 4Å:- Chain D: T.824, L.829, P.830, H.831, G.832, G.1034, M.1036, T.1037, R.1053, L.1059, R.1061, K.1089, S.1092, M.1138, P.1141, I.1142, P.1143, F.1144, N.1145, R.1146
15 PLIP interactions:15 interactions with chain D- Hydrogen bonds: D:T.824, D:G.832, D:T.1037, D:T.1037, D:R.1053, D:S.1092, D:I.1142, D:N.1145, D:N.1145, D:R.1146
- Salt bridges: D:H.831, D:K.1089, D:R.1146, D:R.1146
- pi-Cation interactions: D:R.1053
ACO.14: 20 residues within 4Å:- Chain E: T.824, L.829, P.830, H.831, G.832, G.1034, M.1036, T.1037, R.1053, L.1059, R.1061, K.1089, S.1092, M.1138, P.1141, I.1142, P.1143, F.1144, N.1145, R.1146
15 PLIP interactions:15 interactions with chain E- Hydrogen bonds: E:G.832, E:T.1037, E:T.1037, E:R.1053, E:R.1061, E:S.1092, E:I.1142, E:N.1145, E:N.1145, E:R.1146
- Salt bridges: E:H.831, E:K.1089, E:R.1146, E:R.1146
- pi-Cation interactions: E:R.1053
ACO.17: 20 residues within 4Å:- Chain F: T.824, L.829, P.830, H.831, G.832, G.1034, M.1036, T.1037, R.1053, L.1059, R.1061, K.1089, S.1092, M.1138, P.1141, I.1142, P.1143, F.1144, N.1145, R.1146
15 PLIP interactions:15 interactions with chain F- Hydrogen bonds: F:T.824, F:G.832, F:T.1037, F:T.1037, F:R.1053, F:S.1092, F:I.1142, F:N.1145, F:N.1145, F:R.1146
- Salt bridges: F:H.831, F:K.1089, F:R.1146, F:R.1146
- pi-Cation interactions: F:R.1053
- 6 x QSP: (4~{S})-4-[(2~{R})-3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-2~{H}-1,3-thiazol-2-yl]-4-oxidanyl-4-phosphono-butanoic acid(Non-covalent)
QSP.3: 23 residues within 4Å:- Chain A: H.545, R.546, H.585, S.610, H.611, L.612, G.646, D.647, A.648, A.649, N.680, I.682, G.683, F.684, H.749
- Chain B: E.903, L.949, E.951, Q.975, F.976, F.979, H.1019
- Ligands: MG.1
13 PLIP interactions:2 interactions with chain B, 11 interactions with chain A- Hydrophobic interactions: B:L.949
- pi-Stacking: B:F.979
- Hydrogen bonds: A:S.610, A:L.612, A:D.647, A:A.648, A:A.649, A:H.749, A:H.749
- Salt bridges: A:H.545, A:H.545, A:R.546, A:H.585
QSP.6: 23 residues within 4Å:- Chain A: E.903, L.949, E.951, Q.975, F.976, F.979, H.1019
- Chain B: H.545, R.546, H.585, S.610, H.611, L.612, G.646, D.647, A.648, A.649, N.680, I.682, G.683, F.684, H.749
- Ligands: MG.4
13 PLIP interactions:2 interactions with chain A, 11 interactions with chain B- Hydrophobic interactions: A:L.949
- pi-Stacking: A:F.979
- Hydrogen bonds: B:S.610, B:L.612, B:D.647, B:A.648, B:A.649, B:N.680, B:H.749
- Salt bridges: B:H.545, B:H.545, B:R.546, B:H.585
QSP.9: 24 residues within 4Å:- Chain C: F.512, H.545, R.546, H.585, S.610, H.611, L.612, G.646, D.647, A.648, A.649, N.680, I.682, G.683, F.684, H.749
- Chain D: E.903, L.949, E.951, Q.975, F.976, F.979, H.1019
- Ligands: MG.7
14 PLIP interactions:12 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:F.512, D:L.949
- Hydrogen bonds: C:S.610, C:L.612, C:D.647, C:A.648, C:A.649, C:H.749, C:H.749
- Salt bridges: C:H.545, C:H.545, C:R.546, C:H.585
- pi-Stacking: D:F.979
QSP.12: 24 residues within 4Å:- Chain C: E.903, L.949, E.951, Q.975, F.976, F.979, H.1019
- Chain D: F.512, H.545, R.546, H.585, S.610, H.611, L.612, G.646, D.647, A.648, A.649, N.680, I.682, G.683, F.684, H.749
- Ligands: MG.10
14 PLIP interactions:12 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:F.512, C:L.949
- Hydrogen bonds: D:S.610, D:L.612, D:D.647, D:A.648, D:A.649, D:N.680, D:H.749
- Salt bridges: D:H.545, D:H.545, D:R.546, D:H.585
- pi-Stacking: C:F.979
QSP.15: 23 residues within 4Å:- Chain E: H.545, R.546, H.585, S.610, H.611, L.612, G.646, D.647, A.648, A.649, N.680, I.682, G.683, F.684, H.749
- Chain F: E.903, L.949, E.951, Q.975, F.976, F.979, H.1019
- Ligands: MG.13
15 PLIP interactions:13 interactions with chain E, 2 interactions with chain F- Hydrogen bonds: E:K.510, E:S.610, E:L.612, E:D.647, E:D.647, E:A.648, E:A.649, E:H.749, E:H.749
- Salt bridges: E:H.545, E:H.545, E:R.546, E:H.585
- Hydrophobic interactions: F:L.949
- pi-Stacking: F:F.979
QSP.18: 23 residues within 4Å:- Chain E: E.903, L.949, E.951, Q.975, F.976, F.979, H.1019
- Chain F: H.545, R.546, H.585, S.610, H.611, L.612, G.646, D.647, A.648, A.649, N.680, I.682, G.683, F.684, H.749
- Ligands: MG.16
13 PLIP interactions:2 interactions with chain E, 11 interactions with chain F- Hydrophobic interactions: E:L.949
- pi-Stacking: E:F.979
- Hydrogen bonds: F:S.610, F:L.612, F:D.647, F:A.648, F:A.649, F:N.680, F:H.749
- Salt bridges: F:H.545, F:H.545, F:R.546, F:H.585
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, L. et al., High resolution cryo-EM and crystallographic snapshots of the actinobacterial two-in-one 2-oxoglutarate dehydrogenase. Nat Commun (2023)
- Release Date
- 2023-08-16
- Peptides
- 2-oxoglutarate dehydrogenase E1/E2 component: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.26 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 6 x ACO: ACETYL COENZYME *A(Non-covalent)
- 6 x QSP: (4~{S})-4-[(2~{R})-3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-2~{H}-1,3-thiazol-2-yl]-4-oxidanyl-4-phosphono-butanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, L. et al., High resolution cryo-EM and crystallographic snapshots of the actinobacterial two-in-one 2-oxoglutarate dehydrogenase. Nat Commun (2023)
- Release Date
- 2023-08-16
- Peptides
- 2-oxoglutarate dehydrogenase E1/E2 component: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F